Last reviewed: June 20, 2026
Last updated: June 20, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Administering semaglutide requires knowledge of approved injection locations and rotation patterns to ensure consistent drug absorption and minimize tissue damage. PlexusDx compounded semaglutide injections are prescribed with detailed guidance on injection technique, site selection, and maintenance protocols that support long-term treatment success.
Approved Semaglutide Injection Sites for Safe Administration
Semaglutide injections are administered only in the subcutaneous tissue layer beneath the skin, which lies above muscle. The three primary injection areas approved for this medication are the abdomen, thigh, and upper arm. Each location offers reliable drug delivery when injection depth and angle are correct. Clinical practice standards prioritize these sites because subcutaneous tissue in these areas has consistent thickness and adequate blood flow to support optimal medication absorption.
The abdomen represents the most commonly selected injection site due to its larger surface area and accessibility during self-administration. Injections should be placed at least two finger-widths away from the navel to avoid the periumbilical region. The outer portions of the abdomen, from the ribcage to the groin area, provide multiple injection points for proper site rotation. Many patients find abdominal injections easier to administer independently compared to other body locations.
Thigh and Arm Injection Locations for Rotation Schedules
The front and outer portions of the thigh offer another reliable semaglutide injection site, particularly useful for patients with limited abdominal tissue or those seeking to alternate injection locations weekly. The thigh provides adequate subcutaneous depth and relatively stable tissue composition across different body types. Injections should be placed on the outer thigh area, several inches above the knee and below the hip, avoiding the inner thigh where skin sensitivity and nerve proximity create increased discomfort risk.
Upper arm injections work well for patients with a support person available to assist with administration, though self-injection at this site is possible with practice. The back of the upper arm, between shoulder and elbow on the outer surface, contains sufficient subcutaneous tissue for safe needle penetration. Rotating between abdomen, thighs, and upper arms every week or every injection helps prevent lipohypertrophy, a condition where repeated injections cause abnormal fat accumulation at injection sites.
How to Rotate Injection Sites to Prevent Tissue Damage
Site rotation prevents lipohypertrophy, a complication where scar tissue and fat deposits develop from repeated injections in the same location, potentially affecting medication absorption and causing lumps under the skin. A structured rotation plan involves selecting different injection sites for each weekly dose: abdomen one week, thigh the next week, upper arm the following week, then returning to the abdomen. Within each body area, choose injection points that are at least one inch apart from previous injection locations. This systematic approach distributes injection trauma across multiple tissue sites and maintains consistent drug delivery over months of treatment.
Patients using PlexusDx compounded semaglutide should mark or remember previous injection sites to avoid overlap in rotating sites. Maintaining a simple injection log—noting the date, body area, and specific location—helps track rotation patterns and identify any developing skin changes or lumps. If redness, warmth, swelling, or hard nodules develop at any injection site, notify your healthcare provider immediately, as these signs may indicate infection or severe lipohypertrophy requiring medical evaluation.
Injection Technique and Safety Practices for Optimal Results
Proper injection technique begins with pinching the skin to create a tent-like fold, which elevates subcutaneous tissue and reduces the risk of intramuscular injection. The needle should enter at a 90-degree angle with one smooth motion, neither hesitating nor pushing forcefully. Most semaglutide pens are designed to deliver medication over several seconds; do not remove the needle immediately after the plunger stops, as incomplete injection may result. After the prescribed injection time, withdraw the needle slowly and apply gentle pressure with a clean alcohol pad or sterile gauze for 5-10 seconds to minimize bleeding and bruising.
Patients should always inspect the medication before injection—compounded semaglutide should appear clear or slightly cloudy depending on formulation, with no visible particles or discoloration. Allow injections to reach room temperature if removed from refrigeration, as cold medication may cause increased discomfort upon administration. Never reuse needles, and dispose of used needles in a sharps container or approved medical waste disposal method. Wash hands thoroughly before injection and clean the injection site with an alcohol swab, allowing it to air-dry for 10-15 seconds before administering the dose.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Can I inject semaglutide into muscle instead of under the skin?
No—semaglutide must always be injected into subcutaneous tissue beneath the skin, never into muscle. Intramuscular injection changes medication absorption kinetics and may cause unexpected side effects or reduced efficacy. PlexusDx provides injection guidance to ensure patients administer their compounded semaglutide correctly in approved subcutaneous locations.
How often should I rotate my semaglutide injection sites?
Rotate injection sites with every dose or at minimum every week to prevent lipohypertrophy and ensure consistent medication absorption. Select different body areas in sequence—abdomen, thigh, upper arm—then repeat the cycle. Within each body area, choose injection points at least one inch apart from your previous injection location.
Is it safe to inject semaglutide through clothing or directly on skin?
Always inject through clean, bare skin after cleansing with an alcohol swab and allowing it to air-dry. Injecting through clothing risks introducing bacteria and reduces your ability to properly visualize the injection site and pinch the skin correctly. Preparation takes just 30 seconds and significantly reduces infection risk.
What causes bruising after semaglutide injections and how can I prevent it?
Bruising occurs when injection needles damage small blood vessels in subcutaneous tissue. Preventing bruising requires using a fresh needle for each injection, applying gentle pressure rather than forcing the needle through skin, and avoiding injection sites with visible blood vessels or previous bruises. Applying ice before injection may reduce bleeding, though this is optional.
Does PlexusDx genetic testing help determine the best injection protocol for me?
PlexusDx Precision Peptide Genetic Test identifies genetic variants in GLP1R (rs6923761) and other peptide pathways that influence medication response and tolerance. While genetic testing does not change injection site selection, understanding your genetic predisposition helps your provider optimize your semaglutide dose and monitor you for side effects more effectively. The test is available as a $99 add-on after your first month of treatment.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
When Does Nausea Go Away With Wegovy?
How to Get on Wegovy for Weight Loss: A Comprehensive Guide